Vitruvian Partners-backed KCAS Bioanalytical and Biomarker Services, an Integris BioServices, completed the acquisition of FlowMetric, a provider of flow cytometry and cellular assay R&D services. Financial terms were not disclosed. “We are delighted to partner with the FlowMetric team, accelerating our combined offering to support the industries and customers we serve. We are committed to supporting FlowMetric to expand its technical reach, capacity, and resources through growth investments. KCAS has embarked on significant investments, including a nearly completed 70,000 sq. ft. new facility in Kansas City; Continuing to attract the industry’s top scientific talent and focusing on outstanding customer service; and accelerating internationalization through additional acquisitions. With our investors, Vitruvian Partners, we are optimally positioned to invest in our people and deliver world class services for our growing client base. The acquisition of FlowMetric allows our combined clients access to further operational support to meet the increasing demand we see and to meet the industry’s needs," John Bucksath, KCAS CEO.